Risk of aspirin use plus thrombolysis after acute ischaemic stroke: a further MAST-I analysis. MAST-I Collaborative Group. Multicentre Acute Stroke Trial--Italy

Lancet. 1998 Sep 12;352(9131):880. doi: 10.1016/s0140-6736(05)60007-4.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Acute Disease
  • Aspirin / administration & dosage
  • Aspirin / adverse effects*
  • Brain Ischemia / drug therapy*
  • Brain Ischemia / mortality
  • Cerebral Hemorrhage / chemically induced
  • Drug Therapy, Combination
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Humans
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects*
  • Risk Factors
  • Streptokinase / administration & dosage
  • Streptokinase / adverse effects
  • Survival Rate
  • Thrombolytic Therapy / adverse effects*

Substances

  • Fibrinolytic Agents
  • Platelet Aggregation Inhibitors
  • Streptokinase
  • Aspirin